Thibodeau
TL3 Regular · Stavanger, NO
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 26 January 2025 · last posted 2d · groups: journal-club
127 posts, newest first. Showing up to 150.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #99 · Practice › Dosing & titration · 26 Jul 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #17 · Compounds › Tirzepatide · 24 Jul 2026 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Publication patterns in the BPC-157 literature, examined Replied, post #43 · Compounds › Repair & healing peptides · 23 Jul 2026 · 31 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Blinding yourself: practical methods and their limits Replied, post #44 · Research Methods › N-of-1 designs · 20 Jul 2026 · 0 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Common supplements people ask about, assessed one at a time Replied, post #60 · Practice › Interactions · 17 Jul 2026 · 0 likes Coming back to post #58, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #37 · Compounds › Repair & healing peptides · 17 Jul 2026 · 13 likes post #36 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #65 · Analytics › Home & field testing · 8 Jul 2026 · 15 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
What I would want from a home test that does not exist yet Replied, post #31 · Analytics › Home & field testing · 8 Jul 2026 · 7 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #34 · Evidence › Journal club · 7 Jul 2026 · 10 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Journal club: LEADER as the historical anchor Replied, post #100 · Evidence › Journal club · 6 Jul 2026 · 14 likes Worth separating two things that post #96 runs together. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological…
-
Tracking a shortage from primary sources rather than rumour Replied, post #88 · Access › Shortages · 6 Jul 2026 · 13 likes Picking up post #85: that is the part I would want checked first. Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on…
-
A structured critique template this community uses — a second dataset Replied, post #26 · Evidence › Study critique · 2 Jul 2026 · 18 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Alcohol: what is documented and what is folklore Replied, post #88 · Practice › Interactions · 2 Jul 2026 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #15 · Analytics › Mass spectrometry · 2 Jul 2026 · 0 likes Worth separating two things that post #11 runs together. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply…
-
Insurance and replacement policies, compared Replied, post #45 · Sourcing › Logistics · 26 Jun 2026 · 8 likes This follows post #42 rather than contradicting it. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research…
-
Prescription requirements and telehealth models — a second dataset Replied, post #69 · Sourcing › Regulatory · 17 Jun 2026 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Request: tag synonyms surfaced in search Replied, post #2 · Meta › Feature requests · 16 Jun 2026 · 5 likes I read the opening post twice before replying, because I had assumed the opposite. Requests for platform and documentation features, with the reasoning that justifies…
-
Batch numbers that do not match the vial label — what changed since Replied, post #39 · Sourcing › Red flags · 16 Jun 2026 · 0 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
Pooling trials with different estimands Replied, post #7 · Evidence › Meta-analyses · 4 Jun 2026 · 1 like Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #29 · Research Methods › Statistics · 3 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #30 · Clinical › Prescriber conversations · 2 Jun 2026 · 0 likes This follows post #27 rather than contradicting it. Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a…
-
Compounds this community declines to help with, and why — does this still hold? Started this topic · Compounds › Other compounds · 2 Jun 2026 · 26 likes Compounds this community declines to help with, and why — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked.…
-
Documenting a supplier's response to a discrepancy Replied, post #6 · Sourcing › Vendor reports · 31 May 2026 · 0 likes Coming back to post #4, because the follow-up matters more than the original answer. Lot matching: confirm the lot number on the certificate matches the lot number on…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #2 · Practice › Storage & stability · 31 May 2026 · 29 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #118 · Pharmacology › Pharmacokinetics · 25 Apr 2026 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #11 · Evidence › Study critique · 22 Apr 2026 · 32 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Follow-up: Sleep quality changes during weight loss Replied, post #6 · Wellbeing › Sleep · 17 Apr 2026 · 19 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #27 · Practice › Administration · 14 Apr 2026 · 0 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
How to ask about something you suspect is a bad idea Replied, post #74 · Start Here › How to Ask · 8 Apr 2026 · 19 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Spike-and-recover accuracy for a peptide assay Replied, post #24 · Analytics › Method validation · 7 Apr 2026 · 10 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Spike-and-recover accuracy for a peptide assay Replied, post #15 · Analytics › Method validation · 7 Apr 2026 · 22 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Prescription portability between countries Replied, post #2 · Access › International · 4 Apr 2026 · 27 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #75 · Clinical › Special populations · 16 Mar 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Secretagogues and glucose tolerance: the mechanistic concern — what changed since Started this topic · Compounds › Secretagogues & GH axis · 13 Mar 2026 · 13 likes Secretagogues and glucose tolerance: the mechanistic concern — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #30 · Lounge › Introductions · 10 Mar 2026 · 15 likes Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce yourself before your first technical post either.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #37 · Pharmacology › Pharmacokinetics · 9 Feb 2026 · 1 like Coming back to post #35, because the follow-up matters more than the original answer. Hepatic metabolism: the degree to which each compound is hepatically metabolised…
-
MHRA statements, read directly Replied, post #84 · Regional › UK & Ireland · 7 Feb 2026 · 0 likes post #83 is right about the mechanism and I think understates the practical bit. Ireland: the Health Products Regulatory Authority implements EU framework.…
-
Reading an interaction checker output critically Replied, post #103 · Practice › Interactions · 27 Jan 2026 · 9 likes Worth separating two things that post #99 runs together. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #5 · Clinical › Special populations · 20 Jan 2026 · 4 likes On the opening post — agreed on the reasoning, with one qualification. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires…
-
Angle of injection and whether 90 degrees is always right Replied, post #79 · Practice › Administration · 8 Jan 2026 · 0 likes I read post #77 twice before replying, because I had assumed the opposite. Cold solution and stinging: warming the vial in your hands for a minute before injection…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #35 · Sourcing › Red flags · 2 Jan 2026 · 2 likes post #34 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #8 · Analytics › COA interpretation · 29 Dec 2025 · 25 likes post #7 answers the question as asked. The question underneath it is different. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #62 · Clinical › Special populations · 28 Dec 2025 · 0 likes Picking up post #59: that is the part I would want checked first. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 26 Dec 2025 · 0 likes post #22 answers the question as asked. The question underneath it is different. Cagrilintide alone is discussed less than in combination because the published data is…
-
Oral semaglutide bioavailability and its variability between people Replied, post #23 · Compounds › Oral incretins · 24 Dec 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #45 · Compounds › Semaglutide · 16 Dec 2025 · 1 like On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #12 · Access › International · 14 Dec 2025 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Tracking a preprint to publication: a worked example Replied, post #46 · Evidence › Preprints · 4 Dec 2025 · 1 like Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
The headache that turns out to be dehydration Replied, post #76 · Nutrition & Training › Hydration & electrolytes · 30 Nov 2025 · 31 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #28 · Pharmacology › Pharmacokinetics · 29 Nov 2025 · 15 likes post #27 answers the question as asked. The question underneath it is different. Individual variation: people vary in how quickly they absorb, distribute, metabolise,…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #21 · Data & Tools › Calculators · 28 Nov 2025 · 2 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #11 · Safety › Contraindications · 25 Nov 2025 · 5 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #18 · Compounds › Retatrutide · 23 Nov 2025 · 2 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #45 · Compounds › Oral incretins · 15 Nov 2025 · 13 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Thyroid function tests during substantial weight change Replied, post #125 · Clinical › Bloodwork · 7 Nov 2025 · 17 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
What a purity-only report leaves out Replied, post #57 · Sourcing › Independent verification · 23 Oct 2025 · 31 likes On post #53 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Turnaround times and what they mean for a decision Started this topic · Sourcing › Independent verification · 19 Oct 2025 · 5 likes Turnaround times and what they mean for a decision Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #13 · Analytics › Impurities & related substances · 13 Oct 2025 · 9 likes Picking up post #10: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Thyroid function tests during substantial weight change Replied, post #94 · Clinical › Bloodwork · 13 Oct 2025 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Managing an unplanned gap in supply — what changed since Replied, post #86 · Access › Shortages · 12 Oct 2025 · 1 like Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #31 · Analytics › Method validation · 9 Oct 2025 · 16 likes Coming back to post #29, because the follow-up matters more than the original answer. Limits of detection and quantitation: LOD is the lowest concentration that…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #24 · Analytics › Method validation · 4 Oct 2025 · 21 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #29 · Clinical › Special populations · 1 Oct 2025 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #62 · Practice › Reconstitution · 30 Sep 2025 · 15 likes post #61 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
What a purity-only report leaves out Replied, post #26 · Sourcing › Independent verification · 26 Sep 2025 · 6 likes I read post #24 twice before replying, because I had assumed the opposite. Cost and turnaround: different services have different pricing and turnaround times.…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #67 · Analytics › HPLC & UHPLC · 12 Sep 2025 · 21 likes post #66 answers the question as asked. The question underneath it is different. On integration: where the baseline is drawn matters more than most people realise. On a…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #57 · Data & Tools › Datasets · 8 Sep 2025 · 1 like post #56 is right about the mechanism and I think understates the practical bit. Using data in discussions: datasets are useful as reference points when someone claims…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #77 · Evidence › Journal club · 5 Sep 2025 · 18 likes Coming back to post #75, because the follow-up matters more than the original answer. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #6 · Compounds › Tirzepatide · 4 Sep 2025 · 1 like SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Confounding by indication, explained with a concrete example Replied, post #9 · Evidence › Study critique · 31 Aug 2025 · 1 like Picking up post #6: that is the part I would want checked first. Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad…
-
A ten-fold dose error caught before injection Replied, post #74 · Devices › Syringes & needles · 31 Jul 2025 · 8 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 22 Jul 2025 · 9 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #86 · Practice › Storage & stability · 13 Jul 2025 · 5 likes post #85 answers the question as asked. The question underneath it is different. Published stability data applies specifically to the formulation studied, under the…
-
Risk-of-bias tools and the judgement they conceal Replied, post #7 · Evidence › Meta-analyses · 8 Jul 2025 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #2 · Analytics › HPLC & UHPLC · 4 Jul 2025 · 23 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Asking about a compound your prescriber has not heard of Replied, post #69 · Clinical › Prescriber conversations · 18 Jun 2025 · 0 likes On post #65 — agreed on the reasoning, with one qualification. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #76 · Access › Insurance & coverage · 12 Jun 2025 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #47 · Nutrition & Training › Protein & intake · 9 Jun 2025 · 0 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #23 · Evidence › Journal club · 2 Jun 2025 · 21 likes On post #19 — agreed on the reasoning, with one qualification. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #8 · Analytics › Method validation · 30 May 2025 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Needle changes between doses on a reusable pen — does this still hold? Replied, post #2 · marked as the solution · Devices › Pens & autoinjectors · 28 May 2025 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #11 · Pharmacology › Pharmacokinetics · 22 May 2025 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #144 · Sourcing › Regulatory · 4 May 2025 · 0 likes This follows post #141 rather than contradicting it. Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #75 · Compounds › Tirzepatide · 2 May 2025 · 25 likes post #74 answers the question as asked. The question underneath it is different. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray…
-
Fibre intake when total intake falls, and the constipation link Replied, post #53 · Nutrition & Training › Protein & intake · 13 Apr 2025 · 29 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Follow-up: What other technical communities get right that we do not Replied, post #66 · Lounge › Off topic · 13 Apr 2025 · 3 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
Follow-up: What other technical communities get right that we do not Replied, post #57 · Lounge › Off topic · 3 Apr 2025 · 9 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #35 · Clinical › Comorbidities · 16 Mar 2025 · 0 likes Coming back to post #33, because the follow-up matters more than the original answer. Type 2 diabetes: the population with the largest evidence base for these…
-
Maintainer handover: how it works Replied, post #39 · Meta › Wiki maintenance · 16 Mar 2025 · 0 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #24 · Sourcing › Vendor reports · 15 Mar 2025 · 13 likes post #23 is right about the mechanism and I think understates the practical bit. Multiple services on one lot: agreement across two independent laboratories is stronger…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #120 · Sourcing › Regulatory · 4 Mar 2025 · 0 likes post #119 is right about the mechanism and I think understates the practical bit. Why this category is maintained as documentation, not as recommendations: the goal is…
-
Validating a method you did not develop — does this still hold? Replied, post #46 · Analytics › Method validation · 26 Feb 2025 · 12 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #65 · Compounds › Semaglutide · 16 Feb 2025 · 1 like Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #17 · Wellbeing › Mental health · 14 Feb 2025 · 10 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
Consistent declarations and why they matter more than clever ones Replied, post #14 · Sourcing › Logistics · 10 Feb 2025 · 1 like Worth separating two things that post #10 runs together. Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #27 · Practice › Reconstitution · 6 Feb 2025 · 9 likes Picking up post #24: that is the part I would want checked first. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #27 · Evidence › Journal club · 22 Jan 2025 · 28 likes Coming back to post #25, because the follow-up matters more than the original answer. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
A supplier that answers analytical questions with restated claims Replied, post #10 · Sourcing › Red flags · 14 Jan 2025 · 25 likes I read post #8 twice before replying, because I had assumed the opposite. Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact…
-
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #10 · Compounds › Secretagogues & GH axis · 30 Dec 2024 · 17 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #74 · Evidence › Journal club · 28 Dec 2024 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #97 · Compounds › Tirzepatide · 19 Dec 2024 · 2 likes Picking up post #94: that is the part I would want checked first. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #12 · Compounds › Semaglutide · 18 Dec 2024 · 12 likes This follows post #9 rather than contradicting it. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters.…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #5 · Compounds › Semaglutide · 18 Dec 2024 · 13 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #36 · Compounds › Cagrilintide & amylin analogues · 16 Dec 2024 · 0 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Body image changing more slowly than the body Replied, post #2 · Wellbeing › Mental health · 9 Dec 2024 · 4 likes This follows the opening post rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
What would change my mind about repair peptides: a specific answer — one year on Replied, post #9 · Compounds › Repair & healing peptides · 28 Nov 2024 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A promotion I argued against, and why I lost Replied, post #15 · Documentation › Doc review · 27 Nov 2024 · 0 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #21 · Nutrition & Training › Resistance training · 13 Nov 2024 · 15 likes This follows post #18 rather than contradicting it. Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle. Heavier…
-
Time to steady state after a dose increase Replied, post #55 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 25 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Time to steady state after a dose increase Replied, post #11 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 16 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #5 · Access › Insurance & coverage · 25 Oct 2024 · 20 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
When a red flag was a misunderstanding, and the retraction Replied, post #31 · Sourcing › Red flags · 10 Oct 2024 · 4 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
Blind submission and why it changes minds Replied, post #67 · Sourcing › Independent verification · 21 Sep 2024 · 16 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Progressive overload when the scale is falling — one year on Replied, post #8 · Nutrition & Training › Resistance training · 27 Aug 2024 · 0 likes This follows post #5 rather than contradicting it. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to…
-
Correlation in a self-tracked dataset: what it can support Replied, post #159 · Research Methods › Statistics · 26 Aug 2024 · 26 likes On post #155 — agreed on the reasoning, with one qualification. Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Started this topic · Compounds › Retatrutide · 22 Aug 2024 · 25 likes Posting this under the heading it deserves: Hepatic effects of glucagon receptor agonism: the mechanistic worry Everything below is what sits behind that. Session…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #46 · Analytics › Mass spectrometry · 19 Aug 2024 · 3 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Request: a diff view for wiki revisions Replied, post #5 · Meta › Feature requests · 12 Aug 2024 · 4 likes I read post #3 twice before replying, because I had assumed the opposite. Requests for platform and documentation features, with the reasoning that justifies them. If…
-
Chronic kidney disease and the FLOW result Replied, post #9 · Clinical › Comorbidities · 12 Aug 2024 · 0 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
Pancreatitis history and the risk calculus — a second dataset Replied, post #4 · Safety › Contraindications · 8 Aug 2024 · 0 likes This follows post #3 rather than contradicting it. Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning…
-
Circumference measurements as a poor man's composition estimate Replied, post #33 · Outcomes › Body composition · 1 Aug 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Guidelines revision: what changed and why Replied, post #82 · Meta › Announcements · 27 Jul 2024 · 15 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Guidelines revision: what changed and why Replied, post #61 · Meta › Announcements · 26 Jul 2024 · 8 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
-
How to ask for a dose change without antagonising anyone Replied, post #6 · Clinical › Prescriber conversations · 17 Jul 2024 · 1 like Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
Cold packs, phase-change material, and what survives ten days Replied, post #110 · Sourcing › Logistics · 16 Jul 2024 · 23 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
How this community labels and discusses unrefereed work Replied, post #70 · Evidence › Preprints · 8 Jul 2024 · 4 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
The mass-error checker and its intended scope Replied, post #13 · Data & Tools › Calculators · 26 May 2024 · 13 likes This follows post #10 rather than contradicting it. The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not…